A sex-specific salivary microbe predicts oral mucositis severity following blood cancer treatment
News MIMC atUW News MIMC atUW

A sex-specific salivary microbe predicts oral mucositis severity following blood cancer treatment

In 2022, oncologist Dr. Armin Rashidi joined the Fred Hutchinson Cancer Center (FHCC) to treat patients who receive stem cell transplants for the treatment of blood-related cancers. A new study recently published in npj Biofilms and Microbiomes describes work his group has done to understand microbial predictors of treatment complication severity.

Read More
A gut microbial enzyme that impacts host signaling in undernourished children
News MIMC atUW News MIMC atUW

A gut microbial enzyme that impacts host signaling in undernourished children

Dr. Siddarth Venkatesh, now at the Institute for Systems Biology in Seattle, previously studied the gut microbiome's impact on childhood undernutrition and the therapeutic potential of microbiota-directed complementary food (MDCF) at Washington University. The culmination of that work was published today in Science, where Dr. Venkatesh and coauthors describe a microbial fatty acid amide hydrolase that may be crucial for health in this context.

Read More